Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-026041
Filing Date
2019-05-14
Accepted
2019-05-14 17:02:42
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv521189_10q.htm 10-Q 399618
2 EXHIBIT 31.1 tv521189_ex31-1.htm EX-31.1 7222
3 EXHIBIT 31.2 tv521189_ex31-2.htm EX-31.2 7296
4 EXHIBIT 32.1 tv521189_ex32-1.htm EX-32.1 3764
5 EXHIBIT 32.2 tv521189_ex32-2.htm EX-32.2 3751
  Complete submission text file 0001144204-19-026041.txt   4050026

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20190331.xml EX-101.INS 941472
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20190331.xsd EX-101.SCH 41614
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20190331_cal.xml EX-101.CAL 26476
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20190331_def.xml EX-101.DEF 266340
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20190331_lab.xml EX-101.LAB 294388
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20190331_pre.xml EX-101.PRE 292979
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 19823659
SIC: 2834 Pharmaceutical Preparations